IL70290A - Antimycotic compositions in gel form for the treatment of fungal infections of the oral cavity containing imidazole derivatives - Google Patents

Antimycotic compositions in gel form for the treatment of fungal infections of the oral cavity containing imidazole derivatives

Info

Publication number
IL70290A
IL70290A IL70290A IL7029083A IL70290A IL 70290 A IL70290 A IL 70290A IL 70290 A IL70290 A IL 70290A IL 7029083 A IL7029083 A IL 7029083A IL 70290 A IL70290 A IL 70290A
Authority
IL
Israel
Prior art keywords
treatment
oral cavity
fungal infections
gel form
imidazole derivatives
Prior art date
Application number
IL70290A
Other versions
IL70290A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6178958&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL70290(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL70290A0 publication Critical patent/IL70290A0/en
Publication of IL70290A publication Critical patent/IL70290A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

1. Antimycotic agents in gel form for the treatment of fungal infections of the oral cavity, containing azole derivatives and customary formulating auxiliaries, characterized in that they contain 2.5 % - 17.5 % of cellulose ethers as the gel-forming agent and 0.1 - 1.5 % of xanthan gum as the stabiliser and/or gel-forming agent.
IL70290A 1982-11-25 1983-11-22 Antimycotic compositions in gel form for the treatment of fungal infections of the oral cavity containing imidazole derivatives IL70290A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823243546 DE3243546A1 (en) 1982-11-25 1982-11-25 ANTIMYCOTIC AGENTS IN GEL FOR TREATING FUNGAL INFECTIONS OF THE ORAL CAVES

Publications (2)

Publication Number Publication Date
IL70290A0 IL70290A0 (en) 1984-02-29
IL70290A true IL70290A (en) 1988-01-31

Family

ID=6178958

Family Applications (1)

Application Number Title Priority Date Filing Date
IL70290A IL70290A (en) 1982-11-25 1983-11-22 Antimycotic compositions in gel form for the treatment of fungal infections of the oral cavity containing imidazole derivatives

Country Status (12)

Country Link
EP (1) EP0112485B1 (en)
JP (1) JPS59108712A (en)
KR (1) KR840006766A (en)
AT (1) ATE33759T1 (en)
CA (1) CA1209920A (en)
DE (2) DE3243546A1 (en)
DK (1) DK538683A (en)
ES (1) ES527514A0 (en)
GR (1) GR79726B (en)
IL (1) IL70290A (en)
NO (1) NO834160L (en)
ZA (1) ZA838774B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542020A (en) * 1984-08-17 1985-09-17 E. R. Squibb & Sons, Inc. Long-lasting adhesive antifungal suppositories
JPS61151117A (en) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk Gelatinous antimycotic preparation
DE3614095A1 (en) * 1986-04-25 1987-10-29 Goedecke Ag OXYALKYLCELLULOSE CONTAINING GEL PREPARATION
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US20050054583A1 (en) * 2003-08-20 2005-03-10 Matsumoto Dental University Composition for an antifungal agent for suppressing fungal growth in an oral cavity
JP2005097271A (en) * 2003-08-20 2005-04-14 Matsumoto Shika Univ Composition for antifungal agent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL31756C (en) * 1962-04-26
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US4313765A (en) * 1980-09-24 1982-02-02 Merck & Co., Inc. Synergistic blends of cellulase-free xanthan gum and cellulosics
DE3045915A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF ELASTIC LIQUID PLASTERS
JPS57120576A (en) * 1981-01-20 1982-07-27 Sumitomo Chem Co Ltd Novel imidazole ester
DE3106635A1 (en) * 1981-02-23 1982-09-09 Bayer Ag ANTIMYCOTIC AGENT WITH HIGH ACTIVE SUBSTANCE RELEASE IN THE FORM OF PEN

Also Published As

Publication number Publication date
CA1209920A (en) 1986-08-19
ES8502337A1 (en) 1985-01-01
NO834160L (en) 1984-05-28
DE3243546A1 (en) 1984-05-30
KR840006766A (en) 1984-12-03
ES527514A0 (en) 1985-01-01
EP0112485A2 (en) 1984-07-04
EP0112485A3 (en) 1985-10-23
ATE33759T1 (en) 1988-05-15
JPS59108712A (en) 1984-06-23
DK538683A (en) 1984-05-26
DE3376386D1 (en) 1988-06-01
GR79726B (en) 1984-10-31
IL70290A0 (en) 1984-02-29
EP0112485B1 (en) 1988-04-27
DK538683D0 (en) 1983-11-24
ZA838774B (en) 1984-07-25

Similar Documents

Publication Publication Date Title
AU534447B2 (en) Hydroxyethyl-imidazoles and triazole derivatives and their use as antimycotic actents
HUT41402A (en) Fungicide compositions containing azolyl-methyl-oxirane derivatives and process for preparing the active ingredients
HU178663B (en) Fungicide compositions containing cyanopirrole derivatives as active agents,and process for producing the active agents
PH17937A (en) Imidazole derivatives,their compositions and use thereof
AU8032682A (en) Formulations of known antimycotic azoles
AU536920B2 (en) Hydroxypropyl-triazole derivatives and their use as antimycotic agents
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
IL69825A (en) Triazole derivatives,pharmaceutical compositions containing them and their use as fungicides
ES8504178A1 (en) 1-(1,3-Dioxolan-2-ylmethyl)-azoles, their salts, processes for their preparation and pharmaceutical compositions containing them.
HU185766B (en) Process for producing 1-bracket-2-aryl-1,3-dioxan-2-yl-methyl-bracket closed-1h-imidazol and -1h-1,2,4-triazol derivatives and fungicide compositions containing them as active agents
IL70290A (en) Antimycotic compositions in gel form for the treatment of fungal infections of the oral cavity containing imidazole derivatives
DE2961994D1 (en) Ethene-azole derivatives, process for their preparation, fungicidal compositions and process for their preparation, use of the azole derivatives in combating fungi and process for combating fungi
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
IL69599A (en) Imidazolyl,1,2,4-triazolyl,phenoxy(thio)and phenylamino t-butanol derivatives,their preparation and antimycotic agents containing them
DE3062201D1 (en) Antimycotic compositions containing imidazolylenol ethers, their preparation and their use
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
ES8406191A1 (en) Triazole derivative as an antiviral agent
JPS57209280A (en) Novel triazole and imidazole compound, nanufacture, medicinal or veterinary disinfection composition and plant disinfection composition
IL69610A0 (en) 2-aryl-2-azolylmethyl-1,3-dioxepines,their preparation and their use as plant protection agents
IL65756A (en) N-substituted 2-methylnaphthylamides,their preparation and their use as fungicides
DE3162067D1 (en) Plant-growth regulating compositions containing as active agent 2-methylene-succinamic acid derivatives, and derivatives of this acid useful in these compositions
EP0062236A3 (en) Fungicidal agent containing triazole derivatives, and process for combating fungi therewith
IL69448A0 (en) Fungicidal compositions comprising azolyl derivatives,their preparation and their use
IE830399L (en) Tetrahydropyran derivatives
DE69127435D1 (en) Antiprotozoal agent containing 2-nitroimidazole derivatives